Memantine Grindeks (Memantine Hydrochloride)

Memantine works by blocking the NMDA‑type glutamate receptors in the central nervous system. This non‑competitive antagonism reduces excessive calcium influx that can cause neuronal damage, thereby helping to preserve synaptic function and slow the progression of cognitive symptoms in Alzheimer’s disease.

The appropriate dose of Memantine Grindeks is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions precisely.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas other approved agents such as cholinesterase inhibitors (donepezil, rivastigmine) act by enhancing acetylcholine signaling. Memantine is often used alone or in combination with a cholinesterase inhibitor to target different neurochemical pathways and may provide additional benefit in moderate to severe disease.

Memantine Grindeks should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, heat, and direct sunlight, and ensure the container is tightly closed to maintain stability.

Memantine Grindeks is taken orally, usually once daily after a meal to improve absorption and reduce gastrointestinal discomfort. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks, though uncommon, include seizures, severe allergic reactions (anaphylaxis), and psychiatric disturbances such as hallucinations or psychosis. Patients should seek immediate medical attention if they experience any of these symptoms while on therapy.

Memantine Grindeks is contraindicated in patients with known hypersensitivity to memantine or any of the product’s excipients. Caution is also advised for individuals with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists, unless specifically directed by a physician.